96 related articles for article (PubMed ID: 17627063)
1. International standard reagents for HPV detection.
Pagliusi SR; Garland SM
Dis Markers; 2007; 23(4):283-96. PubMed ID: 17627063
[TBL] [Abstract][Full Text] [Related]
2. Chapter 23: International Standard reagents for harmonization of HPV serology and DNA assays--an update.
Pagliusi SR; Dillner J; Pawlita M; Quint WG; Wheeler CM; Ferguson M
Vaccine; 2006 Aug; 24 Suppl 3():S3/193-200. PubMed ID: 16950007
[TBL] [Abstract][Full Text] [Related]
3. Detection and quantitation of HPV in genital and oral tissues and fluids by real time PCR.
Seaman WT; Andrews E; Couch M; Kojic EM; Cu-Uvin S; Palefsky J; Deal AM; Webster-Cyriaque J
Virol J; 2010 Aug; 7():194. PubMed ID: 20723234
[TBL] [Abstract][Full Text] [Related]
4. Molecular diagnosis of human papillomavirus (HPV) infections.
Molijn A; Kleter B; Quint W; van Doorn LJ
J Clin Virol; 2005 Mar; 32 Suppl 1():S43-51. PubMed ID: 15753011
[TBL] [Abstract][Full Text] [Related]
5. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.
Thai H; Rangwala S; Gay T; Keating K; McLeod S; Nazarenko I; O'Neil D; Pfister D; Loeffert D
J Clin Virol; 2009 Jul; 45 Suppl 1():S93-7. PubMed ID: 19651375
[TBL] [Abstract][Full Text] [Related]
6. A comparative review of laboratory-developed tests utilizing Invader HPV analyte-specific reagents for the detection of high-risk human papillomavirus.
Stillman MJ; Day SP; Schutzbank TE
J Clin Virol; 2009 Jul; 45 Suppl 1():S73-7. PubMed ID: 19651372
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.
Herrero R; Castellsagué X; Pawlita M; Lissowska J; Kee F; Balaram P; Rajkumar T; Sridhar H; Rose B; Pintos J; Fernández L; Idris A; Sánchez MJ; Nieto A; Talamini R; Tavani A; Bosch FX; Reidel U; Snijders PJ; Meijer CJ; Viscidi R; Muñoz N; Franceschi S;
J Natl Cancer Inst; 2003 Dec; 95(23):1772-83. PubMed ID: 14652239
[TBL] [Abstract][Full Text] [Related]
8. Detection and typing of low-risk human papillomavirus genotypes HPV 6, HPV 11, HPV 42, HPV 43 and HPV 44 by polymerase chain reaction and restriction fragment length polymorphism.
Maver PJ; Poljak M; Seme K; Kocjan BJ
J Virol Methods; 2010 Oct; 169(1):215-8. PubMed ID: 20637805
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of AMPLICOR HPV PCR and Linear Array assays on SurePath liquid-based Pap samples for the detection of high-risk HPV genotypes.
Chernesky M; Jang D; Portillo E; Smieja M; Chong S; Buracond S; Klingel M; El Sebai R; Kapala J; Patel J; Biers K; Harroun N; Doucette C; Sumner J
J Clin Virol; 2011 Mar; 50(3):201-4. PubMed ID: 21195020
[TBL] [Abstract][Full Text] [Related]
10. Global proficiency study of human papillomavirus genotyping.
Eklund C; Zhou T; Dillner J;
J Clin Microbiol; 2010 Nov; 48(11):4147-55. PubMed ID: 20844222
[TBL] [Abstract][Full Text] [Related]
11. High performance of a new PCR-based urine assay for HPV-DNA detection and genotyping.
Tanzi E; Bianchi S; Fasolo MM; Frati ER; Mazza F; Martinelli M; Colzani D; Beretta R; Zappa A; Orlando G
J Med Virol; 2013 Jan; 85(1):91-8. PubMed ID: 23097252
[TBL] [Abstract][Full Text] [Related]
12. Rapid detection of the most common high-risk human papillomaviruses by loop-mediated isothermal amplification.
Saetiew C; Limpaiboon T; Jearanaikoon P; Daduang S; Pientong C; Kerdsin A; Daduang J
J Virol Methods; 2011 Dec; 178(1-2):22-30. PubMed ID: 21903136
[TBL] [Abstract][Full Text] [Related]
13. The next-generation Hybrid Capture High-Risk HPV DNA assay on a fully automated platform.
Eder PS; Lou J; Huff J; Macioszek J
J Clin Virol; 2009 Jul; 45 Suppl 1():S85-92. PubMed ID: 19651374
[TBL] [Abstract][Full Text] [Related]
14. Nucleic acid tests for the detection of alpha human papillomaviruses.
Poljak M; Cuzick J; Kocjan BJ; Iftner T; Dillner J; Arbyn M
Vaccine; 2012 Nov; 30 Suppl 5():F100-6. PubMed ID: 23199952
[TBL] [Abstract][Full Text] [Related]
15. Analytical performance evaluation of the HPV OncoCheck assay for detection of high-risk HPV infection in liquid-based cervical samples.
Wang HY; Kim H; Park S; Park KH; Lee H
Exp Mol Pathol; 2019 Feb; 106():149-156. PubMed ID: 30605636
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the detection of HPV-16, 18, 31, 33, and 45 by type-specific DNA- and E6/E7 mRNA-based assays of HPV DNA positive women with abnormal Pap smears.
Salimović-Bešić I; Tomić-Čiča A; Smailji A; Hukić M
J Virol Methods; 2013 Dec; 194(1-2):222-8. PubMed ID: 24036071
[TBL] [Abstract][Full Text] [Related]
17. Post hoc analysis of the PATRICIA randomized trial of the efficacy of human papillomavirus type 16 (HPV-16)/HPV-18 AS04-adjuvanted vaccine against incident and persistent infection with nonvaccine oncogenic HPV types using an alternative multiplex type-specific PCR assay for HPV DNA.
Struyf F; Colau B; Wheeler CM; Naud P; Garland S; Quint W; Chow SN; Salmerón J; Lehtinen M; Del Rosario-Raymundo MR; Paavonen J; Teixeira JC; Germar MJ; Peters K; Skinner SR; Limson G; Castellsagué X; Poppe WA; Ramjattan B; Klein TD; Schwarz TF; Chatterjee A; Tjalma WA; Diaz-Mitoma F; Lewis DJ; Harper DM; Molijn A; van Doorn LJ; David MP; Dubin G;
Clin Vaccine Immunol; 2015 Feb; 22(2):235-44. PubMed ID: 25540273
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the humoral immune response to genital papillomaviruses.
Galloway DA; Jenison SA
Mol Biol Med; 1990 Feb; 7(1):59-72. PubMed ID: 2157937
[TBL] [Abstract][Full Text] [Related]
19. Comparison of oncogenic HPV type-specific viral DNA load and E6/E7 mRNA detection in cervical samples: results from a multicenter study.
Broccolo F; Fusetti L; Rosini S; Caraceni D; Zappacosta R; Ciccocioppo L; Matteoli B; Halfon P; Malnati MS; Ceccherini-Nelli L
J Med Virol; 2013 Mar; 85(3):472-82. PubMed ID: 23280876
[TBL] [Abstract][Full Text] [Related]
20. Novel polymerase chain reaction method for detecting cutaneous human papillomavirus DNA.
Sasagawa T; Mitsuishi T
J Med Virol; 2012 Jan; 84(1):138-44. PubMed ID: 22052582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
